HSL Mobile App 
52 week Low
1,377.20
1,377.20
52 week High
1,960.35
1,960.35
1687.55
Day low
1,682.10
1,682.10
Day high
1,737
1,737
1687.55
Prev Close
1,652.20
1,652.20
Open
1,710.00
1,710.00
6M return
-12.60%
-12.60%
1Y return
5.30%
5.30%
MCap(Rs. in Cr.)
4,04,899.77
4,04,899.77
Total Volume
38,01,939
38,01,939
Face Value : 1
Listed Since
PE Ratio
Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.
P/E RATIO
34.32771
EPS
The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.
EPS
49.16
PRICE/BOOK
Price-to-book ratio is used to compared the company's current market price with its book value.
PRICE/BOOK
5.86
Deliverable
These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.
DELIVERABLES
63.57%
DIV YIELD.(%)
Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.
DIV YIELD.(%)
0.80
Company Details
Check out the key parameters of the company to understand the financial health and stock performance
-
Technical
The key levels help you plan your entry and exit point.
-
PROFIT & LOSS
Take a quick look at the revenues and expenditure sheet.
-
Balance Sheet
Its a statement of assets, liabilities and share capital.
-
Dividend History
Check out the detailed payout data over the last three years.
-
Comparative Returns
Reveals how the stock has fared compared to the BSE, NSE benchmark indices.
Key Level
Resistance 1
1674.63
1674.63
Resistance 2
1697.07
1697.07
Support 1
1634.88
1634.88
Support 2
1617.57
1617.57
Moving Average
20 Days
1722.00
1722.00
50 Days
1698.82
1698.82
100 Days
1752.40
1752.40
200 Days
1756.93
1756.93
Growth in 3 years
Sales
25.46%
Sales Industry Avg
16.38%
PAT
183.29%
PAT Industry Avg
37.18%
25.46%
Sales Industry Avg
16.38%
PAT
183.29%
PAT Industry Avg
37.18%
| Dec 2024 ( in Cr.) | Sep 2024 ( in Cr.) | Jun 2024 ( in Cr.) | Mar 2024 ( in Cr.) | FY 2024 ( in Cr.) | |
|---|---|---|---|---|---|
| Sales | 13,675.46 | 13,291.39 | 12,652.75 | 11,982.90 | 48,496.85 |
| Gross Profit | 4,106.96 | 4,223.79 | 4,078.63 | 3,465.88 | 13,644.53 |
| Operating Profit | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 3,476.40 | 3,597.88 | 3,423.50 | 2,815.52 | 11,087.89 |
| Tax | 558.86 | 567.21 | 552.25 | 148.93 | 1,439.45 |
| Profit After Tax | 2,917.54 | 3,030.67 | 2,871.25 | 2,666.59 | 9,648.44 |
Growth in 3 years
Total Asset Growth
33.57%
Total Liabilities growth
33.57%
Reserves Change
32.77%
33.57%
Total Liabilities growth
33.57%
Reserves Change
32.77%
| Mar 2024 ( in Cr.) | Mar 2023 ( in Cr.) | Mar 2022 ( in Cr.) | Mar 2021 ( in Cr.) | Mar 2019 ( in Cr.) | |
|---|---|---|---|---|---|
| Share Capital | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 |
| Reserves And Surplus | 63,426.82 | 55,755.45 | 47,771.29 | 46,222.85 | 41,169.13 |
| Investments | 15,025.77 | 14,824.34 | 12,848.59 | 9,612.45 | 7,902.53 |
| Total Debt | 4,188.13 | 7,816.01 | 2,309.94 | 4,967.21 | 11,519.06 |
| Total Liabilities | 71,294.10 | 67,131.48 | 53,376.05 | 54,447.04 | 56,241.66 |
| Total Assets | 71,294.10 | 67,131.48 | 53,376.05 | 54,447.04 | 56,241.66 |
750%
Dividend
Date:08 Feb 2023
Dividend Percentage:750
Dividend Type:Interim
400%
Dividend
Date:28 Jul 2023
Dividend Percentage:400
Dividend Type:Final
2023
850%
Dividend
Date:09 Feb 2024
Dividend Percentage:850
Dividend Type:Interim
500%
Dividend
Date:12 Jul 2024
Dividend Percentage:500
Dividend Type:Final
2024 2025
1050%
Dividend
Date:06 Feb 2025
Dividend Percentage:1050
Dividend Type:Interim
2026
Relative to Sensex rtn in 3 year
199.90%
Relative to Nifty rtn in 3 year
182.46%
Relative to top 3 MF rtn in 3 year
199.90%
Relative to Nifty rtn in 3 year
182.46%
Relative to top 3 MF rtn in 3 year
| 1 Year (%) | 2 Year (%) | 3 Year (%) | |
|---|---|---|---|
| Sun Pharma.inds. | 5 | 67 | 82 |
| Bse Sensex | 1 | 26 | 27 |
| Nifty 50 | 1 | 30 | 29 |
| Nifty 500 | -0 | 40 | 35 |
Peer Companies
A quick glance on how stocks from the same sector have performed along with some key parameters
Sun Pharma.Inds.
1687.55 chg : 35.35 (2.14%)
1687.55 chg : 35.35 (2.14%)
Divi`s Lab.
5589.30 chg : 203.15 (3.77%)
5589.30 chg : 203.15 (3.77%)
Cipla
1463.05 chg : 47.45 (3.35%)
1463.05 chg : 47.45 (3.35%)
Torrent Pharma.
3129.00 chg : 2.20 (0.07%)
3129.00 chg : 2.20 (0.07%)
Mankind Pharma
2350.50 chg : 36.55 (1.58%)
2350.50 chg : 36.55 (1.58%)
Return Calculator
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
My investment would be worth 1,05,304.00 with a Gain of 5.30%
Our Research Reports
Stocks and sector-wise Research Reports by HDFC securities help you analyse, understand and take a informed investment decision.
Institutional Reports 11 Apr 2025 4:18 PM
The India Pharma & Healthcare sector is expected to see steady growth and margin improvement during Q4FY25E. We project sales/EBITDA growth of 13%/19% YoY for our coverage universe. Our assumptions a..
Institutional Reports 03 Apr 2025 12:14 PM
The US government under Trump 2.0 has announced reciprocal tariffs across countries, including ~26% tariff on imports from India. However, pharmaceutical products were exempted from the first round o..
Institutional Reports 10 Mar 2025 8:23 PM
Sun Pharmaceutical Industries: Checkpoint acquisition to strengthen specialty business. Maintain BUY
Sun Pharma (SUNP) and Checkpoint Therapeutics Inc. (Checkpoint) have entered into an agreement under which SUNP will acquire Checkpoint, an immunotherapy and targeted oncology company. SUNP will pay ..
Report
Corporate Action
Find out the historical dividend payout and other corporate actions including bonus, stock split and rights issue etc.
D
Dividend
Date:08 Feb 2023
Dividend Percentage:750
D
2023 Dividend
Date:28 Jul 2023
Dividend Percentage:400
D
Dividend
Date:09 Feb 2024
Dividend Percentage:850
D
2024 Dividend
Date:12 Jul 2024
Dividend Percentage:500
D
2025 Dividend
Date:06 Feb 2025
Dividend Percentage:1050
Our Research Analysis
buy Sun Pharmaceutical Industries Ltd
As of today
0%
Target Achived
0%
Target Achived
This call still has potential to give significant positive returns
Potential Upside
-100%
Buy Call with DAY(s) time frame
CMP : 1687.55
Target : 0
Stop Loss : 0
Reco Price : 1568.70
Reco Date :29 Jul 2024
Call Type :SIP
Rationale
History
|
29
Jul 2024 |
Call initiated Target: 0 |
Target Gain -100 % | Reco Price: 1568.70 | Stop loss: 0 | HORIZON : DAY(s) |
As of today
__PERCENT__%
Target Achived
__PERCENT__%
Target Achived
This call still has potential to give significant positive returns
Potential Upside
__TARGETRETURN__%
Buy Call with __TIMEFRAME__ time frame
CMP : __CMP__
Target : __TARGET__
Stop Loss : __STOPLOSS__
Reco Price : __RECOPRICE__
Reco Date :__RECODATE__
Call Type :__CALLTYPE__
__Rationale__
__RECOTYPE__ __COMPANY_NAME__
|
__DATE__
__MONTHYEAR__ |
Call initiated Target: __TARGET__ |
Target Gain __TG__ % | Reco Price: __RP__ | Stop loss: __SL__ | HORIZON : __HORIZN__ |
Our View __RECOTYPE__
FnO
A snapshot on how the stock has performed in the derivatives segment on a real-time basis.
Sun Pharmaceutical Industries Ltd 1,693.70 Chg: 37.25(2.25%) Expiry Month 24 Apr 2025
Day's Low
1,688.00
1,688.00
1,693.70
Day's High
1,739.80
1,739.80
Day’s Open
1,700.00
1,700.00
Prev Close
1,656.45
1,656.45
Volume
37,14,900
37,14,900
OI
1,51,13,350
1,51,13,350
OI Change (%)
-0.41
-0.41
MF Holdings
Here's a list of major funds which hold the stock in their portfolio as of the last reported quarter.
| Scheme Name | AUM (%) | CMV ( in Cr.) | Holding Date |
|---|---|---|---|
| No data available | |||
News
Stay tuned to the latest developments and happenings in the company.
Sun Pharma receives favourable ruling in preliminary injunction delaying launch of LEQSELVI¿
Sun Pharmaceutical Industries announced that on 09 April 2025, the U.S. Court of Appeals for the Federal Circuit held an oral argument on the Company....
10 Apr 2025 13:21Sun Pharmaceutical launches Fexuprazan tablets 40 mg in India
Sun Pharmaceutical Industries has launched Fexuprazan tablets 40 mg in India under the brand name �FEXUCLUE��. FEXUCLUE�, a novel potassium competi....
07 Apr 2025 09:07Sun Pharma completes acquisition of Antibe Therapeutics Inc., Canada
Sun Pharmaceutical Industries has completed 100% acquisition of Antibe Therapeutics Inc., Canada for a total consideration of CAD 4.5 million. ....
18 Mar 2025 15:01Sun Pharmaceuticals Industries consolidated net profit rises 15.04% in the December 2024 quarter
Net profit of Sun Pharmaceuticals Industries rose 15.04% to Rs 2903.38 crore in the quarter ended December 2024 as against Rs 2523.75 crore during the....
01 Feb 2025 07:41Sun Pharmaceuticals Industries consolidated net profit rises 27.98% in the September 2024 quarter
Net profit of Sun Pharmaceuticals Industries rose 27.98% to Rs 3040.16 crore in the quarter ended September 2024 as against Rs 2375.51 crore during th....
28 Oct 2024 16:57Sun Pharmaceuticals Industries consolidated net profit rises 40.20% in the June 2024 quarter
Net profit of Sun Pharmaceuticals Industries rose 40.20% to Rs 2835.62 crore in the quarter ended June 2024 as against Rs 2022.54 crore during the pre....
01 Aug 2024 14:50__heading__
Published on __date__ at __time__
__description__
